Pembrolizumab in Early Triple-Negative Breast Cancer. Reply

  1. Schmid, P.
  2. Cortes, J.
  3. Dent, R.
Revue:
The New England journal of medicine

ISSN: 1533-4406

Année de publication: 2022

Volumen: 386

Número: 18

Pages: 1771-1772

Type: Lettre

DOI: 10.1056/NEJMC2203316 GOOGLE SCHOLAR